Tina's Wish, a non-profit organization dedicated to advancing early detection and prevention research for ovarian cancer, hosted a gala in celebration of 15 years of operation and raised $2.6 million for ovarian cancer early detection research.
Laura Davis Jones, a supporter of Tina's Wish, expressed the urgency of advancing early detection and prevention research for ovarian cancer. She emphasized that such progress can be attained through ongoing funding and innovative research supported by Tina's Wish. Jones stated, "The diagnosis of ovarian cancer is scary and horrific, and the loss of life from ovarian cancer is unacceptable. I firmly believe that early detection is within our reach, and that goal will be achieved by the continued funding of the great research and outside-the-box thinking that is being done through Tina's Wish."
During Ovarian Cancer Awareness Month, over 850 supporters united at the Tina's Wish Gala on September 21st at Pier Sixty in NYC, collectively raising more than $2.6 million for crucial research into early ovarian cancer detection. Tina's Wish pays tribute to the late Tina Brozman, who served as the chief judge of the U.S. Bankruptcy Court for the Southern District of New York and succumbed to ovarian cancer in 2007. To date, the organization has generated more than $24 million in funding for ovarian cancer early detection and prevention research.
According to Tina's Wish, the majority of ovarian cancer cases are diagnosed in advanced stages primarily due to the absence of a reliable early detection method. In fact, statistical data reveals a stark contrast in survival rates between different stages of diagnosis. For women diagnosed at Stage III/IV, the five-year survival rate is a mere 27%, while those diagnosed at Stage I enjoy a significantly higher five-year survival rate of 92%.
According to the American Cancer Society's 2023 estimates for ovarian cancer in the United States, approximately 19,710 women are expected to receive new ovarian cancer diagnoses, while around 13,270 women are projected to lose their lives to this disease. Ovarian cancer ranks fifth in cancer-related deaths among women, surpassing other cancers of the female reproductive system. Women face a lifetime risk of approximately 1 in 78 for developing ovarian cancer, with a lifetime likelihood of ovarian cancer being the cause of death at about 1 in 108.
